Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Behind the scene of diarrhea: a microbial battlefield
  3. Bacterial diarrhea: gut microbiota, a potential victim or a guard against it?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Behind the scene of diarrhea: a microbial battlefield
  3. Bacterial diarrhea: gut microbiota, a potential victim or a guard against it?
Gastroenterology

Bacterial diarrhea: gut microbiota, a potential victim or a guard against it?

Diarrhea
Gastroenterology

Pathogenic bacteria such as Shigella, Vibrio cholerae, Salmonella, E. coli… lead to bacterial diarrhea, through mechanisms that depend on the bacteria involved. Bacterial diarrheas are accompanied by intestinal dysbiosis. Symmetrically, the gut microbiota exerts effects on the bacterial infection. Since a ‘healthy’ gut microbiota is more resistant to infection, probiotics could reduce the severity of many bacterial infections.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

About this article

Created 19 July 2024
Updated 31 July 2024

Underlying how lethal bacterial diarrhea can be, these 8 bacteria were responsible for more than a third of the over 1.65 million deaths from infectious diarrhea recorded worldwide in 2016.2

These 8 bacteria

  • Shigella: 212,438 deaths.
  • Vibrio cholerae: 107,290 deaths.
  • Non-typhoidal Salmonella spp: 84,799 deaths.
  • Campylobacter spp: 75,135 deaths.
  • Enterotoxigenic E. coli: 51,186 deaths.
  • Clostridioides difficile: 22,417 deaths.
  • Aeromonas: 16,881 deaths.
  • Enteropathogenic Escherichia coli: 12,337 deaths.

FROM INFECTION TO DIARRHEA

The mechanisms that lead to bacterial diarrhea depend on the bacteria involved. Transmitted via contaminated food, water or by personto-person contact, Shigella infests the gastrointestinal tract, produces an enterotoxin and serotype toxin 1, destroying the intestinal epithelium and leading to severe bloody and mucous diarrhea.3,5
Pathogenic variants of Vibrio cholerae produce a cholera toxin that activates anion secretion, inhibits absorption of electroneutral NaCl and destroys the intestinal barrier function, thereby inducing massive fluid secretion in the lumen of the small intestine and the loss of large amounts of water, sodium, chloride, bicarbonate and potassium.3,5,13 Different pathogenic E. coli strains, classified into different pathotypes (Table 1), cause mild to severe diarrhea usually accompanied by fever. E. coli adheres to the intestinal epithelial cells through the adherent fimbriae, produces toxins and exerts its pathogenic effects.3,5

Image

EFFECT OF PATHOGENS AND DIARRHEA ON MICROBIOTA

Bacterial diarrheas are accompanied by dysbiosis, usually with an overabundance of facultative anaerobes (Escherichia, Streptococcus, Enterococcus, etc.) in dysenteric diarrhea, and a depletion in bacteria of known immuno-modulatory effects (Lactobacillus ruminis, Bifidobacterium pseudocatenulatum)7 (Figure 3).

Image

For example, in cholera, the gut microbiota is substantially modified both during and after infection, this as a consequence of the removal of the mucus layer along with the residing gut microbial community and of the delivery of toxin by V. cholerae. 13 During recovery, the gut microbiota of cholera patients slowly repopulates via an accumulation pattern similar to that of the maturation of the gut microbiota observed in children.3
In the same way, children infected with diarrheagenic E. coli (DEC) display a distinctive gut microbial composition, with a high fraction of Bacteroidetes and Proteobacteria and a reduced abundance of Firmicutes. 13 Increases in Proteobacteria could be partially explained by an increase in Escherichia/ Shigella species (as the cause of diarrhea) and in other members of Enterobacteriaceae, such as Citrobacter and Enterobacter (related to histamine production induced by proinflammatory environments and associated with E. coli adherence).14 Frequent antimicrobial use can also partly explain the observed dysbiosis.7

 

GUT MICROBIOTA PROTECTION AGAINST INFECTIONS

Symmetrically, the gut microbiota has demonstrated effects on bacterial infection. In germ-free animals, their lack of a gut microbiota and the absence of ecological competition results in an immature immune system that renders them highly susceptible to diarrheal pathogens: 10 colony-forming units (CFU) of Salmonella are enough to cause a lethal infection, whereas to kill 50% of mice with an intact gut microbiota 103 –109 CFU are required.8

In humans, Prevotella, Bifidobacterium and Blautia have been shown to reduce colonization of V. cholerae. Conversely, Paracoccus is believed to support the growth of the pathogen.13 This is the reason why promoting a ‘healthy’ gut microbiome has been considered a useful approach in the intervention and prevention of cholera.13

“The GI tract encompasses ~1 to 10 times more bacterial cells than the number of cells in the human body.” 16

BACTERIAL AND YEAST PROBIOTICS, PREBIOTICS AND FMT

The severity of several bacterial infections could be reduced by probiotics: for example, probiotic E. coli inhibits the biofilm formation of other E. coli strains and likewise those of the pathogenic Staphylococcus aureus and S. epidermidis. 3 Regarding dysentery, a combination of Lactobacillus and Bifidobacterium strains and a Streptococcus strain reduces both the duration of blood-affected diarrhea and the time spent in hospital.3
Numerous mechanisms could explain why probiotics alleviate diarrhea:3 production of antimicrobial substances, competitive exclusion, competition with cell binding sites, production of acids and metabolites that lower the surrounding pH, strengthening of the gut mucosal barrier, modulation of gut mucosal immunity and gut microbiota diversity. For example, the probiotic yeast Saccharomyces boulardii may facilitate gut microbiota restoration in children with acute diarrhea.15

 

Prebiotics can also have a positive impact on diarrhea: by increasing the bacterial production of short-chain fatty acids (SCFAs) such as butyrate, which contribute to the gut barrier integrity; and by antagonizing the adherence of pathogens to epithelial cells, thus inhibiting colonization and promoting gut pathogen elimination.3

 

Fecal microbiota transplantation (FMT), which aims to restore a healthy gut microbiota, has proven effective and is only indicated in the treatment of recurrent C. difficile in both adults and children.14

CLINICAL CASE by Pr. Aldo Maruy

  • A 2-year-old boy presented with fever, abdominal pain and diarrhea with mucus and blood. He had history of two similar episodes in the last six months, treated solely with antibiotics.
     
  • In order to prevent a relapse, it was decided to treat him with antibiotics and probiotics. The diarrhea ceased within 48 hours, the antibiotic was suspended at the 5th day while the probiotic was continued for two weeks; a diet rich in complementary food and prebiotics was prescribed.
     
  • In addition to treating the infection with antibiotics, it is recommended in order to prevent a new diarrheal episode that the composition of the gut microbiota be restored via the diet together with the administration of prebiotics and probiotics

EXPERT OPINION

Throughout one’s life, a healthy microbiota plays an important role in the prevention and treatment of bacterial diarrhea. Specific species have demonstrated protective effects against diarrhea: Lactobacillus taxa are protective against Shigella spp.-induced diarrhea; the presence of Sutterella sp., Prevotella copri and Bacteroides vulgatus predict resistance to enterotoxigenic E. coli (ETEC). On the other hand, microbial intervention, through modifying the diet and using prebiotics, probiotics and FMT, can regulate the composition of gut microbiota to prevent and treat diarrhea. Future research should expand our knowledge of the microbiome as it relates to infectious diarrhea, thereby assisting in the design of improved preventative and managerial interventions.

PR. ALDO MARUY Paediatric Gastroenterologist, Hospital Cayetano Heredia, Lima (Peru)

CONSEQUENCES OF TRAVELERS’ DIARRHEA

When visiting medium- and high-risk destinations, 10–70% of travelers from low infectious disease-risk countries experience diarrhea. Travelers’ diarrhea is predominately caused by bacteria (≥80%–90% of cases), with intestinal viruses accounting for a minimum of 5%–15% of the cases.52 Infections by protozoal pathogens might account for approximately 10% of diagnoses mostly in those traveling for extended periods.

The microbiota of travelers who experienced diarrhea show greater variation throughout the length of their stay than those of healthy travelers, associated with a lower baseline diversity, which has been linked to an increased susceptibility to infection.51

Moreover, diarrhea reduces the capacity of microbiota restoration (large increase of the rate of divergence from baseline) and leads to the acquisition of multidrugresistant organisms.51 Thus, according to a study including 267 Americans travelling outside the United States, a third returned with diarrhea, 61% with intestinal dysbiosis and 38% with antibiotic-resistant bacteria (most of them an E. coli), contributing to the global spread of antimicrobial resistance.58

Enriched in diarrhea:

E. coli, Dorea fomigenerans, Bacteroïdes vulgarus, B. caocae, Odoribacter splanchnicus…,

Depleted in diarrhea:

Ruminococcus bromii, coprococcus, Clostridioides bartlett

Tags
Diarrhea Bacteria Gut microbiota Microbiome Flora
    Focus
    Behind the scene of diarrhea: a microbial battlefield
    • Introduction
      • Microbiota and Infection Diarrhea: virtuous or vicious circle ?
    • Bacterial Diarrhea
      • Bacterial diarrhea: gut microbiota, a potential victim or a guard against it?
      • Focus on antibiotic associated diarrhea (AAD)
    • Viral diarrhea
      • Viral diarrhea: will vaccines change the game ?
    • Parasitic diarrhea
      • Parasitic diarrhea: can the microbiota shape clinical outcomes ?
    • Key take aways
      • Key take aways on diarrhea
    Created 19 July 2024
    Updated 31 July 2024

    About this article

    To know more about this topic.

    Main topic

    Diarrhea

    Medical practice

    Gastroenterology

    Content type

    Dossier detail
    Microbiota and Infection Diarrhea: virtuous or vicious circle ?
    Focus on antibiotic associated diarrhea (AAD)
    Focus

    Behind the scene of diarrhea: a microbial battlefield

    Introduction

    Microbiota and Infection Diarrhea: virtuous or vicious circle ?

    Bacterial Diarrhea

    Bacterial diarrhea: gut microbiota, a potential victim or a guard against it? Focus on antibiotic associated diarrhea (AAD)

    Viral diarrhea

    Viral diarrhea: will vaccines change the game ?

    Parasitic diarrhea

    Parasitic diarrhea: can the microbiota shape clinical outcomes ?

    Key take aways

    Key take aways on diarrhea

    Continue reading

    News

    From diarrhea to chronic diseases: the well-documented consequences of antibiotic-related gut microbiota dysbiosis

    Antibiotic treatment may sometimes take place without any...

    Find out more

    Infectious diarrhea and intestinal microbiota

    A close relationship has been established between childhood gastrointestinal disorders and intestinal micro...

    Find out more
    19.07.2024

    Key take aways on diarrhea

    Read the article

    Parasitic diarrhea: can the microbiota shape clinical outcomes ?

    Not all individuals respond to intestinal infections of parasites in the same way: while some develop no sy...

    Find out more

    Viral diarrhea: will vaccines change the game ?

    Usually presenting as watery diarrhea, viral diarrheas are caused by 5 main types of virus. Among them, rot...

    Find out more

    Microbiota and Infection Diarrhea: virtuous or vicious circle ?

    Find out more
    Actu PRO : La place des parasites dans l’écosystème intestinal
    20.11.2020

    The role of parasites in the intestinal ecosystem

    Read the article
    20.07.2021

    Clostridioides difficile: gut microbiota markers predict the risk of infection

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    04.06.2025

    A handful of bacteria are the signature of chronic pain

    Read the article
    26.05.2025

    Celiac disease: the downside of going gluten-free

    Read the article
    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo